Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
This is the first study to evaluate a novel, protocolized ED-initiated preventive cardiovascular care approach for HLD. If successful, the EMERALD intervention may be able to improve the cardiovascular health for at-risk patients and serve as a use case for other modifiable cardiovascular disease risk factors, such as diabetes, hypertension, tobacco use, and obesity. This single-site study will inform a planned multisite trial.
Authors
- Simon A. Mahler (ORCID: https://orcid.org/0000-0003-2199-4078)
- Anna C. Snavely (ORCID: https://orcid.org/0000-0001-6916-4255)
- Michael D. Shapiro (ORCID: https://orcid.org/0000-0002-9071-3287)
- Sabina B. Gesell (ORCID: https://orcid.org/0000-0002-1997-9816)
- David M. Herrington (ORCID: https://orcid.org/0000-0002-7670-6400)
- Nicklaus P. Ashburn (ORCID: https://orcid.org/0000-0002-3466-8813)
- David M. Reboussin (ORCID: https://orcid.org/0000-0003-1309-2189)
- M. Ehrig
Institutions
- Wake Forest University (US)
Publication Details
- Journal
- Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
- Published
- 2025-04-28
- DOI
- https://doi.org/10.1097/hpc.0000000000000390
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00